Results 41 to 50 of about 961,470 (198)
Diffuse omental cake as an initial presentation of plasma cell leukemia
Journal of Cancer Research and Practice, 2017 Omental cake is a term to describe peritoneal thickening caused by different processes. Metastatic malignancy is the most common cause. Plasma cell leukemia is a rare hematological malignancy involving plasma cells and differ from multiple myeloma in its
Po-Shen Ko +4 more
doaj +1 more source
Metastatic plasma cell leukemia to the skin: a case report with review of the literature
Dermatology Reports, 2021 Plasma cell leukemia (PCL) is a rare variant of leukemia with an aggressive clinical course and a poor prognosis. The cutaneous involvement in PCL is very rare either at clinical presentation of leukemia, namely “leukemia cutis”, or in the metastatic PCL
Elena Pezzolo +2 more
doaj +1 more source
Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2018 Background Exposures to DNA-damaging drugs and ionizing radiations increase risks of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Methods 9,028 recipients of hematopoietic cell autotransplants (1995–2010) for Hodgkin lymphoma (HL; n ...
T. Radivoyevitch +59 more
semanticscholar +1 more source
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents
Cancer, 2018 Primary plasma cell leukemia (pPCL) is an aggressive plasma cell disorder characterized by circulating plasma cells and a poor prognosis. Although patients who have pPCL benefit from the use of stem cell transplantation (SCT) and novel agents, their ...
R. Mina +10 more
semanticscholar +1 more source
International Journal of Hematology-Oncology and Stem Cell Research, 2022 Multiple myeloma constitutes a wide spectrum of diseases ranging from slow-growing monoclonal gammopathy of undetermined significance to rapidly progressing plasma cell leukemia.
Smitha Saldanha +8 more
doaj
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Leukemia and Lymphoma, 2018 This multicenter retrospective study included 101 patients (median age 62 years) with secondary plasma cell leukemia (sPCL). The median time from initial multiple myeloma diagnosis to sPCL was 31 months.
A. Jurczyszyn +33 more
semanticscholar +1 more source
Indian Journal of Pathology and Microbiology, 2016 Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma accounting for 2-3% of all plasma cell dyscrasias characterized by the presence of circulating plasma cells. The diagnosis is based on the % (≥20%) and absolute number (≥2x10 9 /L) of
Prithal Gangadhar +3 more
doaj +1 more source
Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs
Bone Marrow Transplantation, 2018 Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy,
Lohith Gowda +17 more
semanticscholar +1 more source
An interesting series of rare cases of plasma cell neoplasms
Journal of Dr. NTR University of Health Sciences, 2023 Objective: Plasma cell neoplasms are diverse, many of which are rare. The objective of this study is to present a few such rare cases, which will help in better understanding of these diseases and also throw light on how to approach them.
Bhavna Sharma +4 more
doaj +1 more source
BMC Research Notes, 2010 Background Plasma microRNA (miRNA) has become a promising biomarker for detecting cancer; however, it remains uncertain whether miRNA expression levels in plasma reflect those in tumor cells.
Tanaka Masami +6 more
doaj +1 more source